Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis

Journal of Leukocyte Biology

Volumn 101, Issue 2, 2017, Pages 507-517

  Xu, Yanwen ^a   He, Zhongze ^a   Li, Zhaoying ^a   Fang, Shaohong ^a   Zhang, Yun ^a   Wan, Cong ^a   Ma, Yiming ^a   Lin, Peng ^a   Liu, Chuanliang ^a   Wang, Guangyou ^a   Li, Rui ^b   Zhu, Jiwei ^a   Li, Ying ^a   Mu, Lili ^a   Zhang, Yao ^a   Wang, Jinghua ^a   Kong, Qingfei ^a   Li, Hulun ^a   Sun, Bo ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Akt; Differentiation; NF B; Th cell

Indexed keywords

GUANOSINE TRIPHOSPHATASE; IMMUNITY RELATED GTPASE FAMILY MEMBER 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; CLODRONIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; IFI1 PROTEIN, MOUSE; LIPOSOME;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HETEROZYGOTE; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; TH17 CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CELL POLARITY; COCULTURE; DRUG EFFECTS; ENZYME ACTIVATION; GENE SILENCING; IMMUNOLOGY; INFLAMMATION; LYMPH NODE; METABOLISM; PATHOLOGY; TH1 CELL;

ANIMALS; CELL DIFFERENTIATION; CELL POLARITY; CLODRONIC ACID; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME ACTIVATION; FEMALE; GENE SILENCING; GTP-BINDING PROTEINS; HETEROZYGOTE; INFLAMMATION; LIPOSOMES; LYMPH NODES; MACROPHAGES; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; TH1 CELLS; TH17 CELLS; UP-REGULATION;

EID: 85011422864     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0116-028RR     Document Type: Article

References (47)

1. Gold, R., Linington, C., Lassmann, H. (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953–1971.
2. Liblau, R. S., Singer, S. M., McDevitt, H. O. (1995) Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34–38.
3. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., Dong, C. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141.
4. O’Connor, R. A., Anderton, S. M. (2008) Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 193, 1–11.
5. O’Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W., Leech, M. D., Wraith, D. C., Anderton, S. M. (2008) Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181, 3750–3754.
6. Li, H., Ciric, B., Yang, J., Xu, H., Fitzgerald, D. C., Elbehi, M., Fonseca-Kelly, Z., Yu, S., Zhang, G. X., Rostami, A. (2009) Intravenous tolerance modulates macrophage classical activation and antigen presentation in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 208, 54–60.
7. Mensah-Brown, E. P., Shahin, A., Al Shamisi, M., Lukic, M. L. (2011) Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats. J. Neuroimmunol. 232, 68–74.
8. Hamilton, T. A. (2002) Molecular basis of macrophage activation: from gene expression to phenotypic diversity. In The Macrophage, 2nd ed. (B. Bourke, C. Lewis, eds.), Oxford University Press, Oxford, UK, 73–102.
9. Verreck, F. A., de Boer, T., Langenberg, D. M., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., Ottenhoff, T. H. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria. Proc. Natl. Acad. Sci. USA 101, 4560–4565.
10. Mukhopadhyay, S., Mohanty, M., Mangla, A., George, A., Bal, V., Rath, S., Ravindran, B. (2002) Macrophage effector functions controlled by Bruton’s tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance. J. Immunol. 168, 2914–2921.
11. Biswas, S. K., Mantovani, A. (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889–896.
12. Orme, J., Mohan, C. (2012) Macrophage subpopulations in systemic lupus erythematosus. Discov. Med. 13, 151–158.
13. Shechter, R., Schwartz, M. (2013) Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer ‘if’ but ‘how’. J. Pathol. 229, 332–346.
14. Zhao, A., Urban, J. F., Jr., Anthony, R. M., Sun, R., Stiltz, J., van Rooijen, N., Wynn, T. A., Gause, W. C., Shea-Donohue, T. (2008) Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 135, 217–225.e1.
15. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958–969.
16. Mikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., Brochet, B., Canron, M. H., Franconi, J. M., Boiziau, C., Petry, K. G. (2011) Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 17, 2–15.
17. Dungan, L. S., McGuinness, N. C., Boon, L., Lynch, M. A., Mills, K. H. (2014) Innate IFN-g promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages. Eur. J. Immunol. 44, 2903–2917.
18. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., Udalova, I. A. (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231–238.
19. MacMicking, J. D. (2004) IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol. 25, 601–609.
20. Taylor, G. A., Feng, C. G., Sher, A. (2004) p47 GTPases: regulators of immunity to intracellular pathogens. Nat. Rev. Immunol. 4, 100–109.
21. Singh, S. B., Davis, A. S., Taylor, G. A., Deretic, V. (2006) Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438–1441.
22. Gutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., Deretic, V. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753–766.
23. Wellcome Trust Case Control Consortium. (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat. Genet. 39, 830–832.
24. McCarroll, S. A., Huett, A., Kuballa, P., Chilewski, S. D., Landry, A., Goyette, P., Zody, M. C., Hall, J. L., Brant, S. R., Cho, J. H., Duerr, R. H., Silverberg, M. S., Taylor, K. D., Rioux, J. D., Altshuler, D., Daly, M. J., Xavier, R. J. (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease. Nat. Genet. 40, 1107–1112.
25. Xu, H., Wu, Z. Y., Fang, F., Guo, L., Chen, D., Chen, J. X., Stern, D., Taylor, G. A., Jiang, H., Yan, S. S. (2010) Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells. FASEB J. 24, 1583–1592.
26. Wang, C., Wang, C., Dong, H., Wu, X. M., Wang, C., Xia, F., Li, G., Jia, X., He, S., Jiang, X., Li, H., Xu, H. (2013) Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier. Mol. Immunol. 53, 43–51.
27. Taylor, G. A., Stauber, R., Rulong, S., Hudson, E., Pei, V., Pavlakis, G. N., Resau, J. H., Vande Woude, G. F. (1997) The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. J. Biol. Chem. 272, 10639–10645.
28. Taylor, G. A., Collazo, C. M., Yap, G. S., Nguyen, K., Gregorio, T. A., Taylor, L. S., Eagleson, B., Secrest, L., Southon, E. A., Reid, S. W., Tessarollo, L., Bray, M., McVicar, D. W., Komschlies, K. L., Young, H. A., Biron, C. A., Sher, A., Vande Woude, G. F. (2000) Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc. Natl. Acad. Sci. USA 97, 751–755.
29. Halonen, S. K., Taylor, G. A., Weiss, L. M. (2001) Gamma interferoninduced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect. Immun. 69, 5573–5576.
30. Zhang, H. M., Yuan, J., Cheung, P., Luo, H., Yanagawa, B., Chau, D., Stephan-Tozy, N., Wong, B. W., Zhang, J., Wilson, J. E., McManus, B. M., Yang, D. (2003) Overexpression of interferon-gammainducible GTPase inhibits coxsackievirus B3-induced apoptosis through the activation of the phosphatidylinositol 3-kinase/Akt pathway and inhibition of viral replication. J. Biol. Chem. 278, 33011–33019.
31. Tiwari, S., Choi, H. P., Matsuzawa, T., Pypaert, M., MacMicking, J. D. (2009) Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns (3, 4) P (2) and PtdIns (3, 4, 5) P (3) promotes immunity to mycobacteria. Nat. Immunol. 10, 907–917.
32. Tian, L., Li, L., Xing, W., Li, R., Pei, C., Dong, X., Fu, Y., Gu, C., Guo, X., Jia, Y., Wang, G., Wang, J., Li, B., Ren, H., Xu, H. (2015) IRGM1 enhances B16 melanoma cell metastasis through PI3K-Rac1 mediated epithelial mesenchymal transition. Sci. Rep. 5, 12357.
33. Luyendyk, J. P., Schabbauer, G. A., Tencati, M., Holscher, T., Pawlinski, R., Mackman, N. (2008) Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J. Immunol. 180, 4218–4226.
34. Zhao, X., Dai, J., Xiao, X., Wu, L., Zeng, J., Sheng, J., Su, J., Chen, X., Wang, G., Li, K. (2014) PI3K/Akt signaling pathway modulates influenza virus induced mouse alveolar macrophage polarization to M1/M2b. PLoS One 9, e104506.
35. Guha, M., Mackman, N. (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277, 32124–32132.
36. Schabbauer, G., Tencati, M., Pedersen, B., Pawlinski, R., Mackman, N. (2004) PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler. Thromb. Vasc. Biol. 24, 1963–1969.
37. Fang, H., Pengal, R. A., Cao, X., Ganesan, L. P., Wewers, M. D., Marsh, C. B., Tridandapani, S. (2004) Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 173, 360–366.
38. Cao, X., Wei, G., Fang, H., Guo, J., Weinstein, M., Marsh, C. B., Ostrowski, M. C., Tridandapani, S. (2004) The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages. J. Immunol. 172, 4851–4857.
39. Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., Kidd, G., Zorlu, M. M., Sun, N., Hu, W., Liu, L., Lee, J. C., Taylor, S. E., Uehlein, L., Dixon, D., Gu, J., Floruta, C. M., Zhu, M., Charo, I. F., Weiner, H. L., Ransohoff, R. M. (2014) Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211, 1533–1549.
40. Imrich, H., Harzer, K. (2001) On the role of peripheral macrophages during active experimental allergic encephalomyelitis (EAE). J Neural Transm (Vienna) 108, 379–395.
41. Tran, E. H., Hoekstra, K., van Rooijen, N., Dijkstra, C. D., Owens, T. (1998) Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161, 3767–3775.
42. Strachan-Whaley, M., Rivest, S., Yong, V. W. (2014) Interactions between microglia and T cells in multiple sclerosis pathobiology. J. Interferon Cytokine Res. 34, 615–622.
43. Kodama, S., Davis, M., Faustman, D. L. (2005) The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Cell. Mol. Life Sci. 62, 1850–1862.
44. Notley, C. A., Inglis, J. J., Alzabin, S., McCann, F. E., McNamee, K. E., Williams, R. O. (2008) Blockade of tumor necrosis factor in collageninduced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J. Exp. Med. 205, 2491–2497.
45. Batoulis, H., Recks, M. S., Holland, F. O., Thomalla, F., Williams, R. O., Kuerten, S. (2014) Blockade of tumour necrosis factor-a in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology. Clin. Exp. Immunol. 175, 41–48.
46. De Jong, B. A., Huizinga, T. W., Bollen, E. L., Uitdehaag, B. M., Bosma, G. P., van Buchem, M. A., Remarque, E. J., Burgmans, A. C., Kalkers, N. F., Polman, C. H., Westendorp, R. G. (2002) Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J. Neuroimmunol. 126, 172–179.
47. Sutton, C., Brereton, C., Keogh, B., Mills, K. H., Lavelle, E. C. (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685–1691.